These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacotherapy of obsessive-compulsive disorder. Jermain DM; Crismon ML Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535 [TBL] [Abstract][Full Text] [Related]
5. [Biologic markers and prediction of response to treatment in depression]. Uytdenhoef P; Linkowski P; Mendlewicz J Acta Psychiatr Belg; 1982; 82(3):229-42. PubMed ID: 6187184 [No Abstract] [Full Text] [Related]
6. [The treatment of the resistant obsessive-compulsive disorder: an update]. Crespo Facorro B; Gomez-Hernández R Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(1):61-9. PubMed ID: 9133159 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. Goodman WK; Charney DS J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056 [TBL] [Abstract][Full Text] [Related]
8. Biological markers in obsessive-compulsive and affective disorders. Insel TR; Mueller EA; Gillin JC; Siever LJ; Murphy DL J Psychiatr Res; 1984; 18(4):407-23. PubMed ID: 6512711 [TBL] [Abstract][Full Text] [Related]
9. Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse. Marchesi C; Tonna M; Maggini C World J Biol Psychiatry; 2009; 10(4 Pt 2):599-602. PubMed ID: 17853269 [TBL] [Abstract][Full Text] [Related]
10. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates. Lochner C; Hemmings SM; Kinnear CJ; Niehaus DJ; Nel DG; Corfield VA; Moolman-Smook JC; Seedat S; Stein DJ Compr Psychiatry; 2005; 46(1):14-9. PubMed ID: 15714189 [TBL] [Abstract][Full Text] [Related]
11. Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents. Murphy DL; Pato MT; Pigott TA J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):91S-100S. PubMed ID: 1973944 [TBL] [Abstract][Full Text] [Related]
12. SIMILAR AND DISSIMILAR MANIFESTATIONS OF OBSESSIVE-COMPULSIVE NEUROSES IN MONOZYGOTIC TWINS. INOUYE E Am J Psychiatry; 1965 Jun; 121():1171-5. PubMed ID: 14286051 [No Abstract] [Full Text] [Related]
13. The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders. Monzani B; Rijsdijk F; Harris J; Mataix-Cols D JAMA Psychiatry; 2014 Feb; 71(2):182-9. PubMed ID: 24369376 [TBL] [Abstract][Full Text] [Related]
14. Obsessive-compulsive disorder with unusual themes. Gangdev PS S Afr Med J; 1996 Jun; 86(6 Suppl):748, 750. PubMed ID: 9180770 [No Abstract] [Full Text] [Related]
15. Obsessive-Compulsive Disorder, Psychosis, and Bipolarity: A Longitudinal Cohort and Multigenerational Family Study. Cederlöf M; Lichtenstein P; Larsson H; Boman M; Rück C; Landén M; Mataix-Cols D Schizophr Bull; 2015 Sep; 41(5):1076-83. PubMed ID: 25512596 [TBL] [Abstract][Full Text] [Related]
16. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature]. Erfurth A; Schmauss M Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493 [TBL] [Abstract][Full Text] [Related]
18. The genetic contribution to the neuroses. Murray RM; Reveley A Br J Hosp Med; 1981 Feb; 25(2):185-8, 190. PubMed ID: 7194129 [No Abstract] [Full Text] [Related]
19. Pharmacotherapy of obsessive-compulsive disorder. Klein DF Encephale; 1990; 16 Spec No():331-4. PubMed ID: 2209491 [TBL] [Abstract][Full Text] [Related]